Marta Cipriani

Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting

Enrico Attardi, Arianna Savi, Beatrice Borsellino et al. · Blood Advances · 2023 · 27 citations · Full text

Medicine, Hematology, Oncology +13

A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial

Flavia Lombardo, Stefania Spila Alegiani, Flávia Mayer et al. · Trials · 2023 · 12 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial

Fabio Efficace, François‐Xavier Mahon, Johan Richter et al. · Leukemia · 2024 · 11 citations · Full text

Medicine, Oncology, Pharmacology +13

Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients

Alfonso Piciocchi, Marta Cipriani, Monica Messina et al. · eJHaem · 2024 · 10 citations · Full text

Medicine, Hematology, Oncology +17